Victor E. Velculescu

Career Trajectory

Research Cluster Map

Direct collaborators. Node size = influence, colour = community, dashed = past collaboration.

• Data from plasmaCHORD: A Machine Learning Approach to Distinguish Clonal Hematopoiesis–Derived Variants in Liquid Biopsies from Patients with Solid Tumors

  2026-06-17

• Supplementary Data 1 from Epigenetic Instability–Based Metrics in Cell-Free DNA for Early Cancer Detection

  2026-06-17

• Supplementary Figure S2 from plasmaCHORD: A Machine Learning Approach to Distinguish Clonal Hematopoiesis–Derived Variants in Liquid Biopsies from Patients with Solid Tumors

  2026-06-17

• Supplementary Figure S4 from plasmaCHORD: A Machine Learning Approach to Distinguish Clonal Hematopoiesis–Derived Variants in Liquid Biopsies from Patients with Solid Tumors

  2026-06-17

• Data from Epigenetic Instability–Based Metrics in Cell-Free DNA for Early Cancer Detection

  2026-06-17

• Supplementary Figure S1 from plasmaCHORD: A Machine Learning Approach to Distinguish Clonal Hematopoiesis–Derived Variants in Liquid Biopsies from Patients with Solid Tumors

  2026-06-17

• Supplementary Figure S7 from plasmaCHORD: A Machine Learning Approach to Distinguish Clonal Hematopoiesis–Derived Variants in Liquid Biopsies from Patients with Solid Tumors

  2026-06-17

• Supplementary Figure S3 from plasmaCHORD: A Machine Learning Approach to Distinguish Clonal Hematopoiesis–Derived Variants in Liquid Biopsies from Patients with Solid Tumors

  2026-06-17

• Supplementary Figure S5 from plasmaCHORD: A Machine Learning Approach to Distinguish Clonal Hematopoiesis–Derived Variants in Liquid Biopsies from Patients with Solid Tumors

  2026-06-17

• Supplementary Figure S6 from plasmaCHORD: A Machine Learning Approach to Distinguish Clonal Hematopoiesis–Derived Variants in Liquid Biopsies from Patients with Solid Tumors

  2026-06-17

• Supplemental Table 3 from Epigenetic Instability–Based Metrics in Cell-Free DNA for Early Cancer Detection

  2026-06-17

• Supplementary Tables S1-S6 from plasmaCHORD: A Machine Learning Approach to Distinguish Clonal Hematopoiesis–Derived Variants in Liquid Biopsies from Patients with Solid Tumors

  2026-06-17

• Supplemental Table 2 from Epigenetic Instability–Based Metrics in Cell-Free DNA for Early Cancer Detection

  2026-06-17

• Supplemental Table 1 from Epigenetic Instability–Based Metrics in Cell-Free DNA for Early Cancer Detection

  2026-06-17

• plasmaCHORD: A Machine Learning Approach to Distinguish Clonal Hematopoiesis–Derived Variants in Liquid Biopsies from Patients with Solid Tumors

  Clinical Cancer Research · 2026-04-19

• Pembrolizumab and epigenetic modification with azacitidine reshapes the tumor microenvironment of platinum-resistant epithelial ovarian cancer: a phase 2 non-randomized clinical trial

  Communications Medicine · 2026-02-06

• Combining cell-free DNA fragmentomes and total tumour volume improves prognostication and tumour response evaluation in patients with colorectal cancer liver metastases

  EBioMedicine · 2025-12-16 · 4 citations

• Supplementary Tables from Detecting Liver Cancer Using Cell-Free DNA Fragmentomes

  2025-12-11

• Supplementary Figures S1-S14 from Detecting Liver Cancer Using Cell-Free DNA Fragmentomes

  2025-12-11

• Liquid biopsies across the cancer care continuum

  Nature Medicine · 2025-12-01 · 24 citations